ストックスクリーナーアプリを入手
4.67
1.08%
0.05
前日終値:
$4.62
開ける：
$4.58
24時間の取引高:
391.12K
Relative Volume:
0.41
時価総額：
$681.51M
収益：
$389.42M
当期純損益:
$30.70M
株価収益率:
22.86
EPS:
0.2043
ネットキャッシュフロー:
$67.23M
1週間 パフォーマンス:
+1.74%
1か月 パフォーマンス:
-0.21%
6か月 パフォーマンス:
+15.88%
1年 パフォーマンス:
-32.51%
1日の値動き範囲:
$4.58
$4.695
1週間の範囲:
$4.475
$4.695
52週間の値動き範囲:
$3.025
$7.97
Mimedx Group Inc Stock (MDXG) Company Profile
名前
Mimedx Group Inc
セクター
電話
(770) 651-9100
住所
1775 W OAK COMMONS COURT, NE, MARIETTA
Compare MDXG vs VRTX, MRNA, REGN, ARGX, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MDXG
Mimedx Group Inc
|
4.67 | 681.51M | 389.42M | 30.70M | 67.23M | 0.2043 |
VRTX
Vertex Pharmaceuticals Inc
|
510.08 | 129.29B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
225.00 | 89.83B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
746.54 | 76.86B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
825.03 | 51.88B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
189.76 | 40.67B | 742.00K | -1.37B | -1.07B | -7.0731 |
Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-23 | 開始されました | Citizens | Mkt Outperform |
| 2024-07-02 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-03-07 | 開始されました | Lake Street | Buy |
| 2023-10-27 | 開始されました | Craig Hallum | Buy |
| 2022-10-13 | 開始されました | Mizuho | Buy |
| 2021-07-26 | 開始されました | Northland Capital | Outperform |
| 2021-03-19 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Mimedx Group Inc (MDXG) 最新ニュース
MiMedx Group stock gained 1.54 percent on October 6 - AD HOC NEWS
Sanara MedTech Shareholders Approve Merger with MiMedx - The Globe and Mail
What's Driving the Buzz Around MiMedx Group, Inc. (MDXG) in Healthcare Stocks? - Kalkine Media
What Does the AXIOFILL Court Ruling Mean for MiMedx (NASDAQ:MDXG)? - Kalkine Media
MiMedx Group: Court Remands Both Matters to FDA for Further Consideration Consistent With Order >MDXG - Moomoo
MIMEDX Announces Favorable Federal Court Ruling in AXIOFILL® Regulatory Classification Matter - Investing News Network
MIMEDX Announces Favorable Federal Court Ruling in AXIOFILL® Regulatory Classification Matter - globenewswire.com
U.S. District Court Orders FDA to Reclassify MiMedx Wound Powder as Device - Lawxy AI
FDA Must Revisit MiMedx Wound Care Powder Classification - Law360
FDA Must Revisit MiMedx Wound Care Powder Classification - Law360
MiMedx Group, Inc (MDXG) Stock Analysis: Exploring a 53.85% Potential Upside in Biotechnology - DirectorsTalk Interviews
MiMedx Group stock steadies as investors look to upcoming catalysts - AD HOC NEWS
MiMedx Group (MDXG) Holds Steady at $4.76 as Traders Eye $5.00 ResistanceMerger Arbitrage - careplusvn.com
Two New York conferences will include MIMEDX executives on Sept. 9 and 10 - Stock Titan
MIMEDX GROUP, INC. SEC Filing (Sep 8, 2026) - stocktitan.net
MIMEDX to Participate in Upcoming Investor Conferences - Yahoo Finance
MIMEDX to Participate in Upcoming Investor Conferences - GlobeNewswire
Sanara MedTech Seeks Shareholder Approval for Merger With MiMedx - The Globe and Mail
MDXG Should I Buy - Intellectia AI
MiMedx Group (NASDAQ: MDXG) readies shares for business combination - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc.MDXG - Eastern Progress
Sanara MedTech (SMTI) agrees to MiMedx takeover, targeting year-end close - Stock Titan
MiMedx (MDXG) Earnings Metrics: The Bottom-Line Figure Trails Its Comparison at the Close; Immediate Response: Shares Move 3.58% Up on the DayEnergy Earnings Report - vinanet.vn
MDXG Q2 2026 Earnings: Wider-than-Expected Loss as EPS Misses Estimates by 106%Post-Announcement Reaction - vinanet.vn
Tranche Update on MiMedx Group, Inc.'s Equity Buyback Plan announced on February 25, 2026. - marketscreener.com
MiMedx Group (SMTI partner) clarifies Sanara merger fees and $33 cash-plus-stock deal - Stock Titan
Sanara MedTech Corrects Termination Fees in Merger Deal with MiMedx - Kalkine Media
Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock merger terms and corrects fees - Stock Titan
Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock per share in merger - Stock Titan
MiMedx Group, Inc (MDXG) Stock Report: Exploring a 63.93% Potential Upside in the Biotech Arena - DirectorsTalk Interviews
MiMedx Group Inc (MDXG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MiMedx Group, Inc Revenue Breakdown – NASDAQ:MDXG - TradingView
MiMedx Group (MDXG) Climbs 3.83% to $4.34, Approaching Key Resistance LevelSpring Pattern - vinanet.vn
MiMedx (MDXG) Q2 2026 Earnings Call Transcript - AOL.com
MiMedx Group Inc (MDXG) Stock News Today - TradingKey
MiMedx (MDXG) Q2 2026 Earnings Call Transcript - The Globe and Mail
MiMedx Group's (NASDAQ:MDXG) Soft Earnings Are Actually Better Than They Appear - simplywall.st
Lazard Asset Management LLC Sells 264,718 Shares of MiMedx Group, Inc $MDXG - MarketBeat
MiMedx Group (MDXG) Holds Steady Near $4.24 as Consolidation ContinuesExtension Target - vinanet.vn
MiMedx Group (NASDAQ:MDXG) Stock Price Up 7.8%What's Next? - MarketBeat
Renaissance Technologies LLC Has $11.93 Million Stake in MiMedx Group, Inc $MDXG - MarketBeat
Wall Street Zen Downgrades MiMedx Group (NASDAQ:MDXG) to Sell - MarketBeat
Mimedx to buy Sanara for $350M to move beyond wound care - bioworld.com
MiMedx to Buy Sanara MedTech for $350M - Medical Product Outsourcing
MiMedx Group, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
MiMedx to acquire Sanara MedTech for $350M - MassDevice
MiMedx Group: Sanara Deal Comes At A Poor Time - Seeking Alpha
MiMedx Group affirms FY26 sales guidance of $260-290M - scanx.trade
MiMedx Group Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
MiMedx Group Q2 Earnings Call Highlights - tradingview.com
Mimedx Group Inc (MDXG) 財務データ
収益
当期純利益
現金流量
EPS
Mimedx Group Inc (MDXG) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Hulse William Frank IV | General Counsel and CAO |
Mar 10 '26 |
Option Exercise |
4.50 |
136,364 |
613,638 |
624,900 |
| DOUG RICE | Chief Financial Officer |
Mar 10 '26 |
Option Exercise |
4.50 |
243,000 |
1,093,500 |
508,678 |
| Maersk-Moller Kimberly | Chief Commercial Officer |
Nov 06 '25 |
Sale |
7.42 |
58,300 |
432,329 |
236,982 |
| Kimberly Ann Maersk-Moller | Officer |
Nov 06 '25 |
Proposed Sale |
7.33 |
68,587 |
502,743 |
0 |
0.00%
大文字化:
|
ボリューム (24 時間):